Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans

Journal of Clinical Investigation

Volumn 115, Issue 9, 2005, Pages 2524-2533

  Maia, Ana Luiza ^a,c   Kim, Brian W ^b   Huang, Stephen A ^b   Harney, John W ^b   Larsen, P Reed ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IODINE 125; LIOTHYRONINE; RNA; THYROXINE; THYROXINE DEIODINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EUTHYROIDISM; HALF LIFE TIME; HUMAN; HUMAN CELL; LIOTHYRONINE BLOOD LEVEL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THYROID GLAND; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE SYNTHESIS;

CELL LINE; HUMANS; IODIDE PEROXIDASE; IODINE RADIOISOTOPES; LIVER; MOLECULAR STRUCTURE; MUSCLE, SKELETAL; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE;

EID: 24644436920     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI25083     Document Type: Article

References (33)

1. Bianco, A.C., Salvatore, D., Gereben, B., Berry, M.J., and Larsen, P.R. 2002. Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases [review]. Endocr. Rev. 23:38-89.
2. Gereben, B., Goncalves, C., Harney, J.W., Larsen, P.R., and Bianco, A.C. 2000. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol. Endocrinol. 14:1697-1708.
3. Kim, S.W., Harney, J.W., and Larsen, P.R. 1998. Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology. 139:4895-4905.
4. Baqui, M.M., et al. 2003. Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes. J. Biol. Chem. 278:1206-1211.
5. Toyoda, N., Zavacki, A.M., Maia, A.L., Harney, J.W., and Larsen, P.R. 1995. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol. Cell. Biol. 15:5100-5112.
6. Visser, T.J., Kaptein, E., Terpstra, O.T., and Krenning, E.P. 1988. Deiodination of thyroid hormone by human liver. J. Clin. Endocrinol. Metab. 67:17-24.
7. Canani, L.H., et al. 2005. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 90:3472-3478.
8. Silva, J.E., and Larsen, P.R. 1978. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release. J. Clin. Invest. 61:1247-1259.
9. Silva, J.E., and Larsen, P.R. 1977. Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 198:617-620.
10. Baqui, M.M., Gereben, B., Harney, J.W., Larsen, P.R., and Bianco, A.C. 2000. Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. Endocrinology. 141:4309-4312.
11. Moreno, M., et al. 1994. Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase. FEBS Lett. 344:143-146.
12. Curcio, C., et al. 2001. The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line. J. Biol. Chem. 276:30183-30187.
13. Hosoi, Y., et al. 1999. Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J. Clin. Endocrinol. Metab. 84:3293-3300.
14. Buettner, C., Hatney, J.W., and Larsen, P.R. 2000. The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase. Endocrinology. 141:4606-4612.
15. Croceau, W., Bodwell, J.E., Richardson, J.M., and St. Germain, D.L. 1998. Conserved cysteines in the type 1 deiodinase selenoprotein are not essential for catalytic activity. J. Biol. Chem. 273:25230-25236.
16. Shatifi, J., and St. Germain, D.L. 1992. The cDNA for the type I iodothyronine 5′-deiodinase encodes an enzyme manifesting both high Km and low Km activity. Evidence that rat liver and kidney contain a single enzyme which converts thyroxine to 3,5,3′-triiodothyronine. J. Biol. Chem. 267:12539-12544.
17. Curcio-Morelli, C., et al. 2003. In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. Endocrinology. 144:3438-3443.
18. Berry, M.J., Kieffer, J.D., and Larsen, RR. 1991. Evidence that cysteine, not selenocysteine, is in the catalytic site of type II iodothyronine deiodinase. Endocrinology. 129:550-552.
19. Abuid, J., and Larsen, P.R. 1974. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents. J. Clin. Invest. 54:201-208.
20. Geffner, D.L., Azukizawa, M., and Hershman, J.M. 1975. Propylthioutacil blocks extrathyroidal conversion of thyroxine ro triiodothyronine and augments thyrotropin secretion in man. J. Clin. Invest. 55:224-229.
21. Saberi, M., Sterling, F.H., and Utiger, R.D. 1975. Reduction in extrathyroidal triiodothyronine production by propytrhiouracil in man. J. Clin. Invest. 55:218-223.
22. Inada, M., et al. 1975. Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man. J. Clin. Invest. 55:1337-1348.
23. Lum, S.M., Nicoloff, J.T., Spencer, C.A., and Kaptein, E.M. 1984. Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J. Clin. Invest. 73:570-575.
24. Visser, T.J., van der Does-Tobe, I., Docter, R., and Hennemann, G. 1976. Subcellular localization of a rat liver enzyme converting thyroxine into triiodothyronine and possible involvement of essential thiol groups. Biochem. J. 157:479-482.
25. Latsen, P.R., Davies, T.F., Schlumbetger, M.-J., and Hay, I.D. 2003. Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In Williams textbook of endocrinology. P.R. Larsen, H.M. Kronenberg, S. Melmed, and K.S. Polonsky, editors. W.B. Saunders. Philadelphia, Pennsylvania, USA. 331-373.
26. Oppenheimet, J.H., and Schwartz, H.L. 1985. Stereospecific transport to triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain and heart. J. Clin. Invest. 75:147-154.
27. Peeters, R.P., et al. 2003. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J. Clin. Endocrinol. Metab. 88:3202-3211.
28. Brent, G.A., Larsen, P.R., Harney, J.W., Koenig, R.J., and Moore, D.D. 1989. Functional characterization of the rat growth hormone promoter elements requited for induction by thyroid hormone with and without a co-transfected beta type thyroid hormone receptor. J. Biol. Chem. 264:178-182.
29. Everts, M.E., et al. 1994. Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology. 135:2700-2707.
30. Prost, E., Koenig, R.J., Moore, D.D., Larsen, P.R., and Whalen, R.G. 1988. Multiple sequences encoding potential thyroid hormone receptors isolated from mouse skeletal muscle cDNA libraries. Nucleic Acids Res. 16:6248.
31. Callebaut, I., et al. 2003. The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase-clan GH-A-like structure. J. Biol. Chem. 278:36887-36896.
32. Larsen, P.R. 1972. Direct immunoassay of triiodothyronine in human serum. J. Clin. Invest. 51:1939-1949.
33. Richard, K., et al. 1998. Ontogeny of iodothyronine deiodinases in human liver. J. Clin. Endocrinol. Metab. 83:2868-2874.